In summary, for the first time, we demonstrated that PPP2R1A mRNA expression level was elevated in high-grade ovarian serous carcinoma, invasive breast carcinoma, melanoma, lung adenocarcinoma, and bladder carcinoma. The gene discussed is PPP2R1A; the disease is ovarian serous carcinoma.